View in EDS

Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.
Authors: Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy., Buglioni S; Department of Pathology, IRCCS National Cancer Institute Regina Elena, Rome, Italy., Castellano I; Department of Medical Sciences, University of Turin, Turin, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., d'Amati G; Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy., De Angelis C; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy., de Biase D; Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy.; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Pepe F; Department of Public Health, University Federico II of Naples, Naples, Italy., Perrone G; Operative Research Unit of Anatomical Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Medicine, Research Unit of Anatomical Pathology, Università Campus Bio-Medico di Roma, Rome, Italy., Scatena C; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Department of Oncology, Pisa University Hospital, Pisa, Italy., Scatolini M; Molecular Oncology Laboratory, Fondazione Edo ed Elvo Tempia, Ponderano, Biella, Italy., Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.
Source: Pathologica [Pathologica] 2025 Dec; Vol. 117 (6), pp. 546-558.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pacini Editore SpA Country of Publication: Italy NLM ID: 0401123 Publication Model: Print Cited Medium: Internet ISSN: 1591-951X (Electronic) Linking ISSN: 00312983 NLM ISO Abbreviation: Pathologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41954340
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Malapelle+U%22">Malapelle U</searchLink>; Department of Public Health, University Federico II of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Buglioni+S%22">Buglioni S</searchLink>; Department of Pathology, IRCCS National Cancer Institute Regina Elena, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Castellano+I%22">Castellano I</searchLink>; Department of Medical Sciences, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Criscitiello+C%22">Criscitiello C</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22d'Amati+G%22">d'Amati G</searchLink>; Department of Radiological, Oncological and Pathological Sciences, Sapienza-University of Rome, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22De+Angelis+C%22">De Angelis C</searchLink>; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22de+Biase+D%22">de Biase D</searchLink>; Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy.; Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Pepe+F%22">Pepe F</searchLink>; Department of Public Health, University Federico II of Naples, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Perrone+G%22">Perrone G</searchLink>; Operative Research Unit of Anatomical Pathology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Medicine, Research Unit of Anatomical Pathology, Università Campus Bio-Medico di Roma, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Scatena+C%22">Scatena C</searchLink>; Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Department of Oncology, Pisa University Hospital, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Scatolini+M%22">Scatolini M</searchLink>; Molecular Oncology Laboratory, Fondazione Edo ed Elvo Tempia, Ponderano, Biella, Italy.<br /><searchLink fieldCode="AU" term="%22Trapani+D%22">Trapani D</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Venetis+K%22">Venetis K</searchLink>; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Fusco+N%22">Fusco N</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220401123%22">Pathologica</searchLink> [Pathologica] 2025 Dec; Vol. 117 (6), pp. 546-558.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pacini+Editore+SpA%22">Pacini Editore SpA </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0401123 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1591-951X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200312983%22">00312983 </searchLink><i>NLM ISO Abbreviation: </i>Pathologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41954340
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.32074/1591-951X-1531
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 546
    Titles:
      – TitleFull: Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Malapelle U
      – PersonEntity:
          Name:
            NameFull: Buglioni S
      – PersonEntity:
          Name:
            NameFull: Castellano I
      – PersonEntity:
          Name:
            NameFull: Criscitiello C
      – PersonEntity:
          Name:
            NameFull: Curigliano G
      – PersonEntity:
          Name:
            NameFull: d'Amati G
      – PersonEntity:
          Name:
            NameFull: De Angelis C
      – PersonEntity:
          Name:
            NameFull: de Biase D
      – PersonEntity:
          Name:
            NameFull: Pepe F
      – PersonEntity:
          Name:
            NameFull: Perrone G
      – PersonEntity:
          Name:
            NameFull: Scatena C
      – PersonEntity:
          Name:
            NameFull: Scatolini M
      – PersonEntity:
          Name:
            NameFull: Trapani D
      – PersonEntity:
          Name:
            NameFull: Venetis K
      – PersonEntity:
          Name:
            NameFull: Fusco N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1591-951X
          Numbering:
            – Type: volume
              Value: 117
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Pathologica
              Type: main
ResultId 1